Literature DB >> 16987550

Physicochemically modified silicon as a substrate for protein microarrays.

A Jasper Nijdam1, Mark Ming-Cheng Cheng, David H Geho, Roberta Fedele, Paul Herrmann, Keith Killian, Virginia Espina, Emanuel F Petricoin, Lance A Liotta, Mauro Ferrari.   

Abstract

Reverse phase protein microarrays (RPMA) enable high throughput screening of posttranslational modifications of important signaling proteins within diseased cells. One limitation of protein-based molecular profiling is the lack of a PCR-like intrinsic amplification system for proteins. Enhancement of protein microarray sensitivities is an important goal, especially because many molecular targets within patient tissues are of low abundance. The ideal array substrate will have a high protein-binding affinity and low intrinsic signal. To date, nitrocellulose-coated glass has provided an effective substrate for protein binding in the microarray format when using chromogenic detection systems. As fluorescent systems, such as quantum dots, are explored as potential reporter agents, the intrinsic fluorescent properties of nitrocellulose-coated glass slides limit the ability to image microarrays for extended periods of time where increases in net sensitivity can be attained. Silicon, with low intrinsic autofluorescence, is being explored as a potential microarray surface. Native silicon has low binding potential. Through titrated reactive ion etching (RIE), varying surface areas have been created on silicon in order to enhance protein binding. Further, via chemical modification, reactive groups have been added to the surfaces for comparison of relative protein binding. Using this combinatorial method of surface roughening and surface coating, 3-aminopropyltriethoxysilane (APTES) and mercaptopropyltrimethoxysilane (MPTMS) treatments were shown to transform native silicon into a protein-binding substrate comparable to nitrocellulose.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987550     DOI: 10.1016/j.biomaterials.2006.08.051

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

1.  Biofunctionalization on alkylated silicon substrate surfaces via "click" chemistry.

Authors:  Guoting Qin; Catherine Santos; Wen Zhang; Yan Li; Amit Kumar; Uriel J Erasquin; Kai Liu; Pavel Muradov; Barbara Wells Trautner; Chengzhi Cai
Journal:  J Am Chem Soc       Date:  2010-10-29       Impact factor: 15.419

2.  In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice.

Authors:  T Tanaka; B Godin; R Bhavane; R Nieves-Alicea; J Gu; X Liu; C Chiappini; J R Fakhoury; S Amra; A Ewing; Q Li; I J Fidler; M Ferrari
Journal:  Int J Pharm       Date:  2010-09-29       Impact factor: 5.875

3.  Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation.

Authors:  Biana Godin; Jianhua Gu; Rita E Serda; Rohan Bhavane; Ennio Tasciotti; Ciro Chiappini; Xuewu Liu; Takemi Tanaka; Paolo Decuzzi; Mauro Ferrari
Journal:  J Biomed Mater Res A       Date:  2010-09-15       Impact factor: 4.396

4.  Application of physicochemically modified silicon substrates as reverse-phase protein microarrays.

Authors:  A Jasper Nijdam; Michael R Zianni; Edward E Herderick; Mark M-C Cheng; Jenifer R Prosperi; Fredika A Robertson; Emanuel F Petricoin; Lance A Liotta; Mauro Ferrari
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

Review 5.  Nanomedicine--challenge and perspectives.

Authors:  Kristina Riehemann; Stefan W Schneider; Thomas A Luger; Biana Godin; Mauro Ferrari; Harald Fuchs
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 6.  Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use.

Authors:  Samantha Spindel; Kim E Sapsford
Journal:  Sensors (Basel)       Date:  2014-11-25       Impact factor: 3.576

7.  ZnO Nanostructure Templates as a Cost-Efficient Mass-Producible Route for the Development of Cellular Networks.

Authors:  Eleni Makarona; Beatrix Peter; Inna Szekacs; Christos Tsamis; Robert Horvath
Journal:  Materials (Basel)       Date:  2016-03-31       Impact factor: 3.623

Review 8.  Silicon Nanotubes as Potential Therapeutic Platforms.

Authors:  Nguyen T Le; Yuan Tian; Roberto Gonzalez-Rodriguez; Jeffery L Coffer
Journal:  Pharmaceutics       Date:  2019-11-01       Impact factor: 6.321

9.  Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Authors:  Adriana Aguilar-Mahecha; Christiane Cantin; Maureen O'Connor-McCourt; Andre Nantel; Mark Basik
Journal:  Proteome Sci       Date:  2009-04-06       Impact factor: 2.480

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.